13F filer · CIK 1442756
PFM Health Sciences, LP
SAN FRANCISCO, CA · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$1.2B
+$68.7M vs prior
Positions
98
New / sold out
35 / 20
Added / reduced
22 / 41
Turnover
36.6%
buys $414.5M · sells $528.0M
Top-10 weight
33.9%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | ASCENDIS PHARMA A/S | +233,171 | – | +$62.2M |
| New | HUMANA INC | +94,375 | – | +$37.5M |
| New | METTLER TOLEDO INTERNATIONAL | +13,344 | – | +$17.0M |
| New | MERCK & CO INC | +127,118 | – | +$16.3M |
| New | CYTOKINETICS INC | +191,686 | – | +$16.3M |
| New | LANTHEUS HLDGS INC | +146,403 | – | +$16.2M |
| New | CVSCVS HEALTH CORP | +137,457 | – | +$14.2M |
| Added | ICON PUB LTD CO | +78,982 | +137.4% | +$13.7M |
| Added | UNITEDHEALTH GROUP INC | +30,238 | +52.1% | +$12.6M |
| New | GILEAD SCIENCES INC | +90,858 | – | +$11.5M |
47 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | SPDR SERIES TRUSTPUT | -455,300 | -100.0% | $-58.2M |
| Reduced | TENET HEALTHCARE CORP | -271,995 | -68.2% | $-50.9M |
| Sold out | SELECT SECTOR SPDR TRCALL | -238,900 | -100.0% | $-35.0M |
| Sold out | ASCENDIS PHARMA A/S | -152,034 | -100.0% | $-34.8M |
| Reduced | LLYELI LILLY & CO | -26,504 | -40.3% | $-31.8M |
| Sold out | UNITED THERAPEUTICS CORP DELPUT | -45,900 | -100.0% | $-27.2M |
| Reduced | PENUMBRA INC | -79,558 | -56.9% | $-25.1M |
| Sold out | GLAUKOS CORP | -215,685 | -100.0% | $-23.2M |
| Sold out | CENTESSA PHARMACEUTICALS PLC | -528,224 | -100.0% | $-21.0M |
| Sold out | UNITED THERAPEUTICS CORP DELCALL | -31,700 | -100.0% | $-18.8M |
51 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ASCENDIS PHARMA A/SORD SHS | 233,171 | $62.2M | 5.34% |
| 2 | AXSOME THERAPEUTICS INC.COM | 219,596 | $53.8M | 4.61% |
| 3 | LLYELI LILLY & CO | 39,258 | $47.1M | 4.04% |
| 4 | JAZZ PHARMACEUTICALS PLCSHS USD | 160,768 | $38.7M | 3.32% |
| 5 | HUMANA INCCOM | 94,375 | $37.5M | 3.22% |
| 6 | UNITEDHEALTH GROUP INCCOM | 88,276 | $36.7M | 3.15% |
| 7 | NEUROCRINE BIOSCIENCES INCCOM | 213,407 | $36.0M | 3.09% |
| 8 | INHIBRX BIOSCIENCES INCCOM | 308,385 | $29.2M | 2.51% |
| 9 | UNITED THERAPEUTICS CORP DELCOM | 49,991 | $27.1M | 2.32% |
| 10 | REVOLUTION MEDICINES INCCOM | 143,222 | $26.8M | 2.30% |
88 more rows. Subscribe for $29/month to see every row, download the data and use the API.